NOVATEOR

Novateor Research Laboratories Ltd.

BSE: 542771

SME

Sector: Fast Moving Consumer Goods

Industry Group: Personal Products

Industry: Personal Care

32.85+0.2 (+0.61%)

12 May, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

19.88

P/E (TTM)

243.04

P/B

1.89

P/S (TTM)

7.16

EV/EBITDA

CAPE (5Y)

ROE (TTM)

0.67

ROCE (TTM)

-2.42

ROA (TTM)

0.55

Avg 3Y ROE

0.62

Earnings 3Y CAGR

28.56

Sales 3Y CAGR

44.82

Sales 5Y CAGR

82.75

Debt/Equity

0.09

Consensus TP

Strong Buy %

Promoter Holding

50.75

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Novateor Research Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 37.81% for 12-month ended 31 Mar 2026 and the growth was 30.19 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 7.62

Value 37.81

-98.9198.74

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 25.74% for 12-month ended 31 Mar 2026 and the growth was 3.59 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.09 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 243.04 indicates that the stock is expensive on a standalone basis and is at a 479.77% premium to industry median P/E

What is P/E Ratio?

Median: 41.92

Value 243.04

15.05303.53

Low but stable ROE

The company reported low ROE of 0.67% for 12-month ended 31 Mar 2026 and ROE declined marginally by -18 bps from 1 year ago

What is ROE (FY)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low operating margin but improving trend

The company reported low operating margin of -7.57% for 12-month ended 31 Mar 2026 but operating margin improved by 292 bps from 1 year ago

What is Operating profit margin?

Financial Snapshot

See detailed analysis

Multi-year trends for Novateor Research Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Novateor Research Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Novateor Research Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Total Promoter	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	51.60	50.90	50.75
Indian Promoter	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	60.87	51.60	50.90	50.75
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	39.13	39.13	39.13	39.13	39.13	39.13	39.13	39.13	39.13	39.13	39.13	48.40	49.10	49.25
Bodies Corporate	-	-	3.80	8.14	8.39	7.52	4.17	3.67	3.18	3.18	3.18	2.54	2.54	2.54
Others (incl. Retail) No. of shareholders	39.13 128	39.13 89	35.33 161	30.99 151	30.74 135	31.61 128	34.96 109	35.46 104	35.95 109	35.95 113	35.95 151	45.86 155	46.56 163	46.71 163

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Novateor Research Laboratories Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Shivam Varma	27 Dec 2023	buy	₹ 36.34	36.00 k	₹ 13.08 lac
Kailashben Ashokkumar Patel	18 Aug 2023	buy	₹ 29.21	42.00 k	₹ 12.27 lac
Amit Jugraj Jain	14 Dec 2022	buy	₹ 20.06	30.00 k	₹ 6.02 lac
Vivid Mercantile Limited	09 Sep 2022	sell	₹ 11.20	30.00 k	₹ 3.36 lac
Kamal Gadalay	28 Jan 2022	sell	₹ 7.64	30.00 k	₹ 2.29 lac
Heena S Jain	29 Sep 2021	sell	₹ 11.63	36.00 k	₹ 4.19 lac
Suresh Gadaley	29 Sep 2021	buy	₹ 11.62	30.00 k	₹ 3.49 lac
Murugesanmaris	14 Jun 2021	buy	₹ 7.97	30.00 k	₹ 2.39 lac

No corporate action data available.

Company Profile

Overview of Novateor Research Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Novateor Research Laboratories Limited is an India-based company, which is engaged in the development of personal care products. The Company’s teeth whitening products are sold under the brand name SmiloShine. The Company manufactures three different variants of teeth whitening strips, teeth whiteni...

Key personnel

Mrs. Pooja Bafna Rathi

Compliance Officer, Company Secretary

Mr. Navdeep Subhashbhai MehtaD

Chief Financial Officer, Managing Director, Director

Ms. Hiral Nischal BaneD

Additional Independent Director

Mr. Imran Zuber KhanD

Additional Independent Director

Mr. Anil Tilakraj AroraD

Non-Executive Independent Director

Mr. Bhavya Himanshu DoshiD

Additional Non-Executive Independent Director

Incorporated on

01 Apr 2011

Last Annual

31 Mar 2026

Last Interim

No. of Employees

IPO date

13 Sep 2019

Free Float

21,22,440

Website

https://novateor.com/

Phone no.

+919979961759

Address

B-1001 Titanium City Center, Near Dhananjay Tower,, 100 Feet Ring Road, Near Shyamal Cross Road., Anand Nagar, AHMEDABAD, 380015, India

Frequently Asked Questions

What is the current share price of Novateor Research Laboratories Ltd.?

The current share price of Novateor Research Laboratories Ltd. is ₹ 32.85 as of 12 May 2026.

What is the market capitalisation of Novateor Research Laboratories Ltd.?

The market capitalisation of Novateor Research Laboratories Ltd. stands at ₹ 19.88 Cr.

What is the PE ratio of Novateor Research Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Novateor Research Laboratories Ltd. is 243.04 as of the latest trailing twelve months data.

What is the ROE and ROCE of Novateor Research Laboratories Ltd.?

Novateor Research Laboratories Ltd. has a Return on Equity (ROE) of 0.67% and a Return on Capital Employed (ROCE) of -2.42% as per the latest financial reports.

What is the 52-week high and low of Novateor Research Laboratories Ltd.?

The 52-week high of Novateor Research Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Novateor Research Laboratories Ltd.?

The dividend yield of Novateor Research Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Novateor Research Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 46.71% of Novateor Research Laboratories Ltd. shares.

What sector does Novateor Research Laboratories Ltd. belong to?

Novateor Research Laboratories Ltd. operates in the Fast Moving Consumer Goods sector.

What is the beta of Novateor Research Laboratories Ltd.?

The beta of Novateor Research Laboratories Ltd. is 0.45, indicating its price volatility relative to the broader market.

What is the RSI of Novateor Research Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Novateor Research Laboratories Ltd. is 51.69, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Novateor Research Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Novateor Research Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile